Quantcast

Latest Anterior ischemic optic neuropathy Stories

2005-07-08 15:31:02

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved new labeling to warn men about possible blindness from Pfizer Inc.'s Viagra and other drugs for erectile dysfunction. Cialis, sold by Eli Lily & Co. and Icos Corp., and Levitra, which is co-promoted by GlaxoSmithKline and Bayer AG, will also carry new labels. Pfizer agreed last month to change the popular impotence drug's label but said a company review found no evidence of increased risk of blindness in...